Who are Hydroquinone cream's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hydroquinone Methyl Ether, Shade Uvaguard, Infuvite Adult, Bleaching Agents, Tri-luma, LTC 15 minutes.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hydroquinone-cream.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hydroquinone cream — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hydroquinone cream (Hydroquinone cream) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Depigmenting agent. Area: Dermatology.

marketed Depigmenting agent Tyrosinase Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Hydroquinone cream (Hydroquinone cream) — National Skin Centre. Hydroquinone inhibits melanin production by suppressing tyrosinase activity in melanocytes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Hydroquinone cream TARGET	Hydroquinone cream	National Skin Centre	marketed	Depigmenting agent	Tyrosinase
Hydroquinone Methyl Ether	MEQUINOL		marketed	Skin Lightening Agent	Tyrosinase	1999-01-01
Shade Uvaguard	AVOBENZONE	Bayer	marketed	avobenzone	Tyrosinase	1992-01-01
Infuvite Adult	ASCORBIC ACID		marketed	Vitamin C [EPC]	Tyrosinase	1985-01-01
Bleaching Agents	Bleaching Agents	André Luis Faria e Silva	marketed	Topical depigmenting agent	Tyrosinase (primary); melanin (direct oxidation)
Tri-luma	Tri-luma	Hexsel Dermatology Clinic	marketed	Topical depigmenting agent combination	Tyrosinase; retinoic acid receptor; glucocorticoid receptor
LTC 15 minutes	LTC 15 minutes	Netherlands Institute for Pigment Disorders	marketed	Skin lightening agent	Tyrosinase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Depigmenting agent class)

Islamabad Medical and Dental College · 1 drug in this class
National Skin Centre · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hydroquinone cream — Competitive Intelligence Brief. https://druglandscape.com/ci/hydroquinone-cream. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing